Patent AnalyticsExaminers
Menu

Application

16624758 · USE OF CELL-FREE CIRCULATING RNA (cfRNA) EXPRESSION OF PD-L1 AND ERCC1 IN PLASMA TO MONITOR RESPONSE TO THERAPY IN NSCLC

Filed 2019-12-19 · Abandoned The official file ↗ · Art unit 1634 · Examiner Daniel Ward Nielsen · CPC C12Q 1/68 · Liquid Genomics, Inc. · Umberg Zipser, LLP

Office actions
2
first was Restriction requirement
RCEs
0
no appeal
To first action
9.6 mo
to disposition 24.3 mo
Statutes raised
101 103 112
2 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in